Myocardial Edema and Ischemia in Coronary Microvascular Embolization
نویسندگان
چکیده
Background. Oxygen-derived free radicals are thought to injure the ischemic heart during coronary microvascular embolization. Methods and Results. To test this idea, microspheres (15 gm in diameter) were repetitively administered into the left anterior descending coronary artery to cause microvascular embolization in dogs. Myocardial contractile and metabolic dysfunctions were significantly attenuated after treatments with recombinant human superoxide dismutase, an acyl derivative of ascorbic acid (CV3611, 2-0-octadecylascorbic acid), and xanthine oxidase inhibitor (allopurinol). The free radical scavengers and inhibitor enhanced the coronary hyperemic flow response during embolization, and the total number of microspheres causing maximal embolization was increased by these drugs. When 8-phenyltheophylline was additionally administered with superoxide dismutase, these beneficial effects were abolished, indicating that coronary effects of these drugs may be due to increased release of adenosine during coronary microvascular embolization. Conclusions. We conclude that oxygen radicals worsen the ischemic injury in coronary microembolization. (Circulation 1991;84:828-840)
منابع مشابه
Role of oxygen-derived free radicals in myocardial edema and ischemia in coronary microvascular embolization.
BACKGROUND Oxygen-derived free radicals are thought to injure the ischemic heart during coronary microvascular embolization. METHODS AND RESULTS To test this idea, microspheres (15 microns in diameter) were repetitively administered into the left anterior descending coronary artery to cause microvascular embolization in dogs. Myocardial contractile and metabolic dysfunctions were significantl...
متن کاملAspirating and filtering atherothrombotic debris during percutaneous coronary intervention.
he coronary “no-reflow” phenomenon can occur during eperfusion of an infarct artery or after percutaneous coroary intervention (PCI) (1). It represents inadequate myoardial perfusion despite epicardial coronary artery patency nd can be caused by reperfusion injury, embolization of therosclerotic or thrombotic debris, or ischemia-induced icrovascular damage from endothelial cell injury, leukoyte...
متن کاملCan Multimodal Invasive Imaging Be Used to Predict Periprocedural Myocardial Infarctions?
M ore than 1 million percutaneous coronary interventions (PCIs) are performed per year in the United States. Although technological advances have significantly improved outcomes following PCI, 5% to 44% of PCI patients still experience periprocedural myocardial infarction (PMI). PMI can be either macro-sized (coronary dissection or occlusion of a side branch) or microvascular such as distal emb...
متن کاملCoronary Microvascular Obstruction
During the past decades, advances in percutaneous coronary intervention and antithrombotic therapy have improved the prognosis of patients with ST-segment–elevation myocardial infarction (STEMI). However, in a substantial number of STEMI patients, myocardial perfusion remains impaired despite successful recanalization of the infarct-related epicardial coronary artery, and this scenario has been...
متن کاملIntracoronary administration of abciximab in ST-elevation myocardial infarction.
Primary percutaneous coronary intervention (PCI) is now the preferred method of treating patients with STelevation myocardial infarction (STEMI). Despite restoration of epicardial flow, microvascular obstruction may persist after primary PCI as a result of both atheromatous and thrombotic embolization, neutrophil plugging, edema, and vasospasm.1–3 Therefore, studies such as the one by Thiele et...
متن کامل